BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25672575)

  • 1. Body Mass Index and Doses at Organs at Risk in a Mediterranean Population Treated with Postoperative Vaginal Cuff Brachytherapy.
    Sabater S; Arenas M; Berenguer R; Andres I; Jimenez-Jimenez E; Martos A; Fernandez-Lopez J; Sevillano M; Rovirosa A
    Cancer Res Treat; 2015 Jul; 47(3):473-9. PubMed ID: 25672575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric analysis of rectal filling on rectal doses during vaginal cuff brachytherapy.
    Sabater S; Arenas M; Berenguer R; Machin-Hamalainen S; Andres I; Sevillano MM; Jimenez-Jimenez E; Martos A; Lopez-Honrubia V; Fernandez-Lopez J
    Brachytherapy; 2015; 14(4):458-63. PubMed ID: 25900391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
    Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY
    Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
    Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
    Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
    Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
    Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose accumulation during vaginal cuff brachytherapy based on rigid/deformable registration vs. single plan addition.
    Sabater S; Andres I; Sevillano M; Berenguer R; Machin-Hamalainen S; Arenas M
    Brachytherapy; 2014; 13(4):343-51. PubMed ID: 24388615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of body mass index on rectal dose in locally advanced cervical cancer treated with high-dose-rate brachytherapy.
    Lim J; Durbin-Johnson B; Valicenti R; Mathai M; Stern RL; Mayadev J
    Brachytherapy; 2013; 12(6):550-4. PubMed ID: 23706512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-application displacement of brachytherapy dose received by the bladder and rectum of the patients with inoperable cervical cancer.
    Marosevic G; Ljuca D; Osmic H; Fazlic S; Arsovski O; Mileusnic D
    Radiol Oncol; 2014 Jun; 48(2):203-9. PubMed ID: 24991211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vaginal cylinder position on dose distribution in patients with endometrial carcinoma in treatment of vaginal cuff brachytherapy.
    Ozdemir Y; Dolek Y; Onal C
    J Contemp Brachytherapy; 2017 Jun; 9(3):230-235. PubMed ID: 28725246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged treatment planning can increase real rectal dose in 3D brachytherapy for cervical cancer.
    Vlachová Z; Dolezel M; Svozilova K; Jaskova P; Vitaskova D; Matzenauer M; Stuk J; Hartmann I
    J Contemp Brachytherapy; 2020 Apr; 12(2):118-123. PubMed ID: 32395135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal contrast increases rectal dose during vaginal cuff brachytherapy.
    Sabater S; Andres I; Jimenez-Jimenez E; Berenguer R; Sevillano M; Lopez-Honrubia V; Rovirosa A; Sanchez-Prieto R; Arenas M
    Brachytherapy; 2016; 15(1):35-9. PubMed ID: 26612699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver variability in rectum contouring in high-dose-rate brachytherapy for prostate cancer: A multi-institutional prospective analysis.
    Chicas-Sett R; Celada-Alvarez F; Roldan S; Rodriguez-Villalba S; Santos-Olias M; Soler-Catalan P; Ibanez-Rosello B; Arribas L; Tormo A; Benlloch JM; Perez-Calatayud J
    Brachytherapy; 2018; 17(1):208-213. PubMed ID: 29113782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vaginal gauze packing technique with or without balloon in high-dose-rate brachytherapy of uterine cervical cancer: A crossover randomized controlled trial.
    Dhanapalan R; Pandjatcharam J; Saravanan K; Patil NH
    J Contemp Brachytherapy; 2022 Dec; 14(6):551-559. PubMed ID: 36819474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric and cost comparison of first fraction imaging versus fractional re-imaging on critical organ dose in vaginal cuff brachytherapy.
    Corso CD; Jarrio C; Nunnery EW; Ali AN; Ghavidel S; Rossi PJ; Diaz R
    Pract Radiat Oncol; 2013; 3(4):256-62. PubMed ID: 24674395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the organs at risk be contoured in vaginal cuff brachytherapy?
    Holloway CL; Macklin EA; Cormack RA; Viswanathan AN
    Brachytherapy; 2011; 10(4):313-7. PubMed ID: 21193355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between 2D and 3D planning of high-dose-rate vaginal cuff brachytherapy in patients with stage I-II endometrial cancer using cobalt-60.
    Hashemi FA; Mansouri S; Aghili M; Esmati E; Babaei M; Saeedian A; Moalej S; Jaberi R
    J Contemp Brachytherapy; 2021 Oct; 13(5):526-532. PubMed ID: 34759977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-cavitary brachytherapy in endometrial carcinoma: experience with cobalt-60 source.
    Rullán JAD; Miguelañez MTM; Fernández RC; Gallego MC; Sánchez MM; Vicente FG; García SS
    J Contemp Brachytherapy; 2022 Jun; 14(3):227-232. PubMed ID: 36199999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.